{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T08:54:19Z","timestamp":1777107259318,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Brain Tissue Resource Center","award":["MH\/NS 31862"],"award-info":[{"award-number":["MH\/NS 31862"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1016\/s0002-9440(10)62554-0","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T05:03:18Z","timestamp":1296190998000},"page":"1269-1278","source":"Crossref","is-referenced-by-count":145,"title":["Levels of Nonphosphorylated and Phosphorylated Tau in Cerebrospinal Fluid of Alzheimer's Disease Patients"],"prefix":"10.1016","volume":"160","author":[{"given":"Yuan Yuan","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan Shu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu Hong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Grundke-Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0002-9440(10)62554-0_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archneur.56.3.281","article-title":"Biomarkers of Alzheimer disease","volume":"56","author":"Growdon","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib2","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0006-8993(99)01092-6","article-title":"Soluble interleukin-1 receptor type II levels are elevated in cerebral fluid in Alzheimer disease","volume":"826","author":"Garlind","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/S0002-9440(10)62554-0_bib3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archneur.56.6.655","article-title":"Cerebrospinal fluid opens a window on Alzheimer disease","volume":"56","author":"Galasko","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib4","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1212\/WNL.54.10.2009","article-title":"Increased CSF level of never growth factor in patients with Alzheimer disease","volume":"54","author":"Hock","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/S0002-9440(10)62554-0_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ana.111","article-title":"Tracking of Alzheimer disease progression with CSF tau protein phosphorylated at threonine 231","volume":"49","author":"Hampel","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid (1-42) in Alzheimer disease: differences between early and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib8","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410380414","article-title":"Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease","volume":"389","author":"Arai","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0304-3940(95)11297-A","article-title":"Increased cerebrospinal fluid tau in patients with Alzheimer disease","volume":"186","author":"Jensen","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0304-3940(95)11291-4","article-title":"Tau in cerebrospinal fluid: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau","volume":"186","author":"Mori","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00002093-199812000-00020","article-title":"Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease","volume":"12","author":"Kurz","year":"1998","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/S0002-9440(10)62554-0_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1212\/WNL.52.8.1555","article-title":"Improved discrimination of AD patients using \u03b2-amyloid(1-42) and tau levels in CSF","volume":"52","author":"Hulstaert","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/S0002-9440(10)62554-0_bib13","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1212\/WNL.54.7.1498","article-title":"Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF","volume":"54","author":"Kahle","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/S0002-9440(10)62554-0_bib14","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau: a component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9440(10)62554-0_bib15","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule associated protein \u03c4 (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)62554-0_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0197-4580(95)00033-B","article-title":"Alzheimer abnormally phosphorylated tau is more hyperphosphorylated than the fetal tau and causes the disruption of microtubules","volume":"16","author":"Iqbal","year":"1995","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S0002-9440(10)62554-0_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/0896-6273(93)90057-X","article-title":"Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding","volume":"10","author":"Bramblett","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/S0002-9440(10)62554-0_bib18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF01888367","article-title":"Tau protein kinase I\/GSK-3beta\/kinase FA in heparin phosphorylates tau on Ser199, Thr231, Ser235, Ser262, Ser396 and Ser400 sites phosphorylated in Alzheimer disease brain","volume":"14","author":"Song","year":"1995","journal-title":"J Protein Chem"},{"key":"10.1016\/S0002-9440(10)62554-0_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(98)01090-4","article-title":"Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase","volume":"436","author":"Wang","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib20","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1074\/jbc.270.9.4854","article-title":"Dephosphorylation of Alzheimer paired helical filaments with protein phosphatase 2A and 2B","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9440(10)62554-0_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0169-328X(95)00316-K","article-title":"Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1","volume":"38","author":"Wang","year":"1996","journal-title":"Mol Brain Res"},{"key":"10.1016\/S0002-9440(10)62554-0_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(99)00476-0","article-title":"Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease","volume":"270","author":"Ishiguro","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-1759(86)90337-6","article-title":"Enzyme amplification for immunoassays. Detection limit of one hundredth of an attomole","volume":"87","author":"Johannsson","year":"1986","journal-title":"J Immunol Methods"},{"key":"10.1016\/S0002-9440(10)62554-0_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-5793(94)01445-7","article-title":"Rapid Alzheimer-like phosphorylation of tau by the synergistic actions of non-proline-dependent protein kinases and GSK-3","volume":"358","author":"Singh","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib25","doi-asserted-by":"crossref","first-page":"24374","DOI":"10.1016\/S0021-9258(20)80536-5","article-title":"Microtubule associated protein tau: abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease","volume":"268","author":"K\u00f6pke","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9440(10)62554-0_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0169-328X(88)90017-4","article-title":"Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments","volume":"4","author":"Grundke-Iqbal","year":"1988","journal-title":"Mol Brain Res"},{"key":"10.1016\/S0002-9440(10)62554-0_bib27","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1471-4159.1992.tb09432.x","article-title":"Brain levels of microtubule associated protein tau are elevated in Alzheimer's disease brain: a radioimmunoslot-blot assay for nanograms of the protein","volume":"59","author":"Khatoon","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/S0002-9440(10)62554-0_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","article-title":"Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains","volume":"351","author":"Khatoon","year":"1994","journal-title":"FEBS Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib29","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1074\/jbc.270.2.823","article-title":"Proline-directed and non-proline-directed phosphorylation of PHF-tau","volume":"270","author":"Morishima-Kawashima","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0002-9440(10)62554-0_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01178-2","article-title":"Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients","volume":"287","author":"Kohnken","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9440(10)62554-0_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.1054","article-title":"Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 1999 for the antemortem diagnosis of Alzheimer's disease","volume":"50","author":"Itoh","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib32","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/jnnp.70.5.624","article-title":"Both total and phosphorylated tau are increased in Alzheimer's disease","volume":"70","author":"Sjogren","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0002-9440(10)62554-0_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/eji.1830010518","article-title":"A method for quantitative determination of cellular immunoglobulins by enzyme-labeled antibodies","volume":"1","author":"Avrameas","year":"1971","journal-title":"Eur J Immunol"},{"key":"10.1016\/S0002-9440(10)62554-0_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0167-5699(84)90027-6","article-title":"The avidin-biotin complex","volume":"5","author":"Wilchek","year":"1984","journal-title":"Immunol Today"},{"key":"10.1016\/S0002-9440(10)62554-0_bib35","article-title":"Avidin-biotin technology","volume":"vol. 184","author":"Wilchek","year":"1990"},{"key":"10.1016\/S0002-9440(10)62554-0_bib36","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1073\/pnas.76.10.5336","article-title":"Ultrasensitive enzymatic radioimmunoassay: application to detection of cholera toxin and rotavirus","volume":"76","author":"Harris","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0002-9440(10)62554-0_bib37","doi-asserted-by":"crossref","first-page":"6923","DOI":"10.1073\/pnas.121119298","article-title":"Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments\/straight filaments","volume":"98","author":"Alonso","year":"2001","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010625540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010625540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T05:13:23Z","timestamp":1637212403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010625540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S0002944010625540"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9440(10)62554-0","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}